Cargando…
P717: AG946, A PYRUVATE KINASE (PK) ACTIVATOR IMPROVES PK PROPERTIES AND RED BLOOD CELL (RBC) METABOLISM UPON EX VIVO TREATMENT OF RBCS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROMES
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429337/ http://dx.doi.org/10.1097/01.HS9.0000969772.59102.e2 |
| _version_ | 1785090687409061888 |
|---|---|
| author | de Wilde, Jonathan Ruiter, Titine van Oirschot, Brigitte Jans, Judith Dang, Lenny Wind-Rotolo, Megan van Solinge, Wouter van Rhenen, Anna Van Wijk, Richard Rab, Minke |
| author_facet | de Wilde, Jonathan Ruiter, Titine van Oirschot, Brigitte Jans, Judith Dang, Lenny Wind-Rotolo, Megan van Solinge, Wouter van Rhenen, Anna Van Wijk, Richard Rab, Minke |
| author_sort | de Wilde, Jonathan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429337 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104293372023-08-17 P717: AG946, A PYRUVATE KINASE (PK) ACTIVATOR IMPROVES PK PROPERTIES AND RED BLOOD CELL (RBC) METABOLISM UPON EX VIVO TREATMENT OF RBCS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROMES de Wilde, Jonathan Ruiter, Titine van Oirschot, Brigitte Jans, Judith Dang, Lenny Wind-Rotolo, Megan van Solinge, Wouter van Rhenen, Anna Van Wijk, Richard Rab, Minke Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429337/ http://dx.doi.org/10.1097/01.HS9.0000969772.59102.e2 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters de Wilde, Jonathan Ruiter, Titine van Oirschot, Brigitte Jans, Judith Dang, Lenny Wind-Rotolo, Megan van Solinge, Wouter van Rhenen, Anna Van Wijk, Richard Rab, Minke P717: AG946, A PYRUVATE KINASE (PK) ACTIVATOR IMPROVES PK PROPERTIES AND RED BLOOD CELL (RBC) METABOLISM UPON EX VIVO TREATMENT OF RBCS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROMES |
| title | P717: AG946, A PYRUVATE KINASE (PK) ACTIVATOR IMPROVES PK PROPERTIES AND RED BLOOD CELL (RBC) METABOLISM UPON EX VIVO TREATMENT OF RBCS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROMES |
| title_full | P717: AG946, A PYRUVATE KINASE (PK) ACTIVATOR IMPROVES PK PROPERTIES AND RED BLOOD CELL (RBC) METABOLISM UPON EX VIVO TREATMENT OF RBCS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROMES |
| title_fullStr | P717: AG946, A PYRUVATE KINASE (PK) ACTIVATOR IMPROVES PK PROPERTIES AND RED BLOOD CELL (RBC) METABOLISM UPON EX VIVO TREATMENT OF RBCS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROMES |
| title_full_unstemmed | P717: AG946, A PYRUVATE KINASE (PK) ACTIVATOR IMPROVES PK PROPERTIES AND RED BLOOD CELL (RBC) METABOLISM UPON EX VIVO TREATMENT OF RBCS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROMES |
| title_short | P717: AG946, A PYRUVATE KINASE (PK) ACTIVATOR IMPROVES PK PROPERTIES AND RED BLOOD CELL (RBC) METABOLISM UPON EX VIVO TREATMENT OF RBCS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROMES |
| title_sort | p717: ag946, a pyruvate kinase (pk) activator improves pk properties and red blood cell (rbc) metabolism upon ex vivo treatment of rbcs from patients with myelodysplastic syndromes |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429337/ http://dx.doi.org/10.1097/01.HS9.0000969772.59102.e2 |
| work_keys_str_mv | AT dewildejonathan p717ag946apyruvatekinasepkactivatorimprovespkpropertiesandredbloodcellrbcmetabolismuponexvivotreatmentofrbcsfrompatientswithmyelodysplasticsyndromes AT ruitertitine p717ag946apyruvatekinasepkactivatorimprovespkpropertiesandredbloodcellrbcmetabolismuponexvivotreatmentofrbcsfrompatientswithmyelodysplasticsyndromes AT vanoirschotbrigitte p717ag946apyruvatekinasepkactivatorimprovespkpropertiesandredbloodcellrbcmetabolismuponexvivotreatmentofrbcsfrompatientswithmyelodysplasticsyndromes AT jansjudith p717ag946apyruvatekinasepkactivatorimprovespkpropertiesandredbloodcellrbcmetabolismuponexvivotreatmentofrbcsfrompatientswithmyelodysplasticsyndromes AT danglenny p717ag946apyruvatekinasepkactivatorimprovespkpropertiesandredbloodcellrbcmetabolismuponexvivotreatmentofrbcsfrompatientswithmyelodysplasticsyndromes AT windrotolomegan p717ag946apyruvatekinasepkactivatorimprovespkpropertiesandredbloodcellrbcmetabolismuponexvivotreatmentofrbcsfrompatientswithmyelodysplasticsyndromes AT vansolingewouter p717ag946apyruvatekinasepkactivatorimprovespkpropertiesandredbloodcellrbcmetabolismuponexvivotreatmentofrbcsfrompatientswithmyelodysplasticsyndromes AT vanrhenenanna p717ag946apyruvatekinasepkactivatorimprovespkpropertiesandredbloodcellrbcmetabolismuponexvivotreatmentofrbcsfrompatientswithmyelodysplasticsyndromes AT vanwijkrichard p717ag946apyruvatekinasepkactivatorimprovespkpropertiesandredbloodcellrbcmetabolismuponexvivotreatmentofrbcsfrompatientswithmyelodysplasticsyndromes AT rabminke p717ag946apyruvatekinasepkactivatorimprovespkpropertiesandredbloodcellrbcmetabolismuponexvivotreatmentofrbcsfrompatientswithmyelodysplasticsyndromes |